MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Potential BlockBuster Technology and/or Business Model
FDA _ Priority Review Voucher
Attachments
704207
Parents
*FDA: Key Terms & Designations
Potential BlockBuster Technology and/or Business Model
Children
Ultragenyx Pharmaceuticals Inc. (NASDAQ:RARE)*
Jumps
FDA _ Accelerated Approval
FDA _ Breakthrough Devices Program
FDA _ Breakthrough Therapy Designation
FDA _ Commissioner's National Priority Voucher (CNPV) Pilot Program
FDA _ Fast Track Designation
FDA _ HDE (Humanitarian Device Exemptions)
FDA _ Orphan Drug Designation
FDA _ Priority Review
FDA _ Rare Pediatric Disease Designation
FDA _ Regenerative Medicine Advanced Therapy (RMAT)